SRDX Surmodics Inc.: Long-Term Debt to Capital Coefficient

Surmodics, Inc. (SRDX) controls the market through unique formulations for medical devices, allowing the company to regularly index the cost of reagents. A patent shield creates powerful inertial demand and a stable cash flow. The business also relies on the production of ophthalmological coatings and payments from major pharmaceutical companies. The current metric is 0.26. The security's price action shown below clearly demonstrates the dynamics of these processes.

This ratio determines the degree of long-term leverage by comparing liabilities with a maturity of over one year against equity to assess the business's financial stability. By analyzing the long-term debt-to-equity trend on GURU.Markets, an investor can see the balance between default risk and borrowing efficiency, which is critical for Surmodics, Inc. (SRDX) during the modernization of its automated coating lines.